Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Leuk Lymphoma. 2017 Jul 18;59(4):821–828. doi: 10.1080/10428194.2017.1352089

Figure 1.

Figure 1

CD25 expression status and mutational profile of 55 sequenced patients. Patients underwent next generation sequencing using a targeted exome panel of 30 genes recurrently mutated in AML. Mutations were called if the variant allele frequency was 4%. Each column represents a single patient's profile while the top axis depicts the total number of mutations per patient. Gene names are represented on the right axis and the percent of patients in the cohort with that mutation depicted on the left axis. The specific type of genetic alteration is noted in the figure legend.